News

Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call Transcript
Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ETCompany ParticipantsBryan Giraudo - COO & CFOFaheem Hasnain ...
Belite Bio Inc (BLTE) Q1 2025 Earnings Call Highlights: Strong Financial Position Amid Rising ...
Belite Bio Inc (BLTE) showcases promising trial progress and a robust cash runway, despite increased R&D and G&A expenses leading to a higher net loss.
Biomednewsbreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts As Fingerprint Drug Testing Expands Globally
Intelligent Bio Solutions (NASDAQ: INBS) reported continued commercial growth, surpassing 450 active accounts with 35 added in fiscal Q3, driven by ...
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...
Taiwan News9h
Gene Expression Analysis Market to Grow at 8.8% CAGR, Surpassing USD 3 Billion by 2026
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw153 ...
Taiwan News9h
Microarray Market to Exceed USD 4 Billion, Growing at Over 9% CAGR by 2026
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw156 ...
Belite Bio signals positive DSMB review and targets 500-patient PHOENIX trial enrollment completion in Q3 2025 while maintaining strong cash runway
Q1 2025 Management View CEO Tom Lin reported continued progress in advancing Tinlarebant for Stargardt's disease and ...
Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights
Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experienceAnnounced selection of IL15-superagonist as first payload to be delivere ...